Clofazimine is an antileprotic medication and phenazine derivative primarily indicated for the treatment of multibacillary leprosy and erythema nodosum leprosum. By inhibiting mycobacterial DNA synthesis… Read more















Clofazimine is an antileprotic medication and phenazine derivative primarily indicated for the treatment of multibacillary leprosy and erythema nodosum leprosum. By inhibiting mycobacterial DNA synthesis and disrupting bacterial cell membranes, this drug effectively manages these conditions. Laboratories utilize this extensive collection of Clofazimine reference standards, including pharmacopeial and non-pharmacopeial impurities, to support rigorous quality control and method validation processes. The catalogue features various related compounds, such as degradation products and metabolites, which are essential for precise impurity profiling and stability testing. Additionally, stable isotope labelled compounds are available to serve as high-quality internal standards for mass spectrometry-based analytical assays. These materials provide the reliability necessary for ensuring the consistency and safety of pharmaceutical formulations, assisting researchers and analysts in achieving accurate characterization of the active ingredient and its complex related substances throughout the drug development lifecycle.